| Discipline name | Position | Best Scientists | Publications | D-Index |
|---|---|---|---|---|
| Medicine | 488 | 349 | 324 | 35 |
The journal explores disciplines such as Internal medicine, Cardiology, Intensive care medicine, Atrial fibrillation and Myocardial infarction. As a part of it, discussions in Internal medicine involve topics like Stroke, Hazard ratio, Heart failure, Percutaneous coronary intervention and Aspirin. Topics in Hazard ratio were tackled in line with various other fields like Lower risk, Proportional hazards model and Cohort study.
The Percutaneous coronary intervention study featured in European Heart Journal - Cardiovascular Pharmacotherapy draws connections with the study of Conventional PCI. The majority of Aspirin studies presented zero in on Clopidogrel. It explores themes in Cardiology like Ejection fraction, Antithrombotic and Coronary artery disease and links them with other fields of study like In patient.
In it, Clinical trial, Diabetes mellitus, Randomized controlled trial, Pharmacotherapy and Disease are investigated in conjunction with one another to address concerns in Intensive care medicine research. In the Atrial fibrillation research discussed, Warfarin, Rivaroxaban, Apixaban, Dabigatran and Vitamin K antagonist are all tackled. Myocardial infarction studies presented in it focus on topics such as Ticagrelor and Acute coronary syndrome.
The journal articles explore disciplines such as Internal medicine, Intensive care medicine, Cardiology, Disease and Diabetes mellitus. The Internal medicine research presented in the journal articles focuses mostly on Endocrinology and, on occasion, topics in Sleep in non-human animals. The published papers facilitate discussions in Coronary artery disease as part of the larger field of Cardiology, however, they also tackle fields such as In patient.
The scientific interests tackled in European Heart Journal - Cardiovascular Pharmacotherapy are Internal medicine, Cardiology, Atrial fibrillation, Stroke and Randomized controlled trial. Attendees of it participated in discussions that delve into both Internal medicine and In patient. The journal tackles studies in Kidney disease and the interrelated subject of Diabetes mellitus to gain insights into Cardiology.
It deals with Atrial fibrillation in conjunction with Cohort and similar fields in Observational study. While work presented in the journal provided substantial information on Stroke, it also covered topics in Apixaban, Rivaroxaban, Edoxaban and Dosing. Randomized controlled trial research featured in European Heart Journal - Cardiovascular Pharmacotherapy incorporates concerns from various other topics such as Regimen, Placebo and Subgroup analysis.
A key indicator for each journal is its effectiveness in reaching other researchers with the papers published at that venue.
The chart below presents the interquartile range (first quartile 25%, median 50% and third quartile 75%) of the number of citations of articles over time.
The top authors publishing in European Heart Journal - Cardiovascular Pharmacotherapy (based on the number of publications) are:
The overall trend for top authors publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top authors.
Only papers with recognized affiliations are considered
The top affiliations publishing in European Heart Journal - Cardiovascular Pharmacotherapy (based on the number of publications) are:
The overall trend for top affiliations publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top affiliations.
The publication chance index shows the ratio of articles published by the best research institutions in the journal edition to all articles published within that journal. The best research institutions were selected based on the largest number of articles published during all editions of the journal.
The chart below presents the percentage ratio of articles from top institutions (based on their ranking of total papers).Top affiliations were grouped by their rank into the following tiers: top 1-10, top 11-20, top 21-50, and top 51+. Only articles with a recognized affiliation are considered.
During the most recent 2021 edition, 2.48% of publications had an unrecognized affiliation. Out of the publications with recognized affiliations, 35.03% were posted by at least one author from the top 10 institutions publishing in the journal. Another 20.38% included authors affiliated with research institutions from the top 11-20 affiliations. Institutions from the 21-50 range included 19.75% of all publications and 24.84% were from other institutions.
A very common phenomenon observed among researchers publishing scientific articles is the intentional selection of journals they have already attended in the past. In particular, it is worth analyzing the case when the authors participate in the same journal from year to year.
The Returning Authors Index presented below illustrates the ratio of authors who participated in both a given as well as the previous edition of the journal in relation to all participants in a given year.
The graph below shows the Returning Institution Index, illustrating the ratio of institutions that participated in both a given and the previous edition of the conference in relation to all affiliations present in a given year.
Our experience to innovation index was created to show a cross-section of the experience level of authors publishing in a journal. The index includes the authors publishing at the last edition of a journal, grouped by total number of publications throughout their academic career (P) and the total number of citations of these publications ever received (C).
The group intervals were selected empirically to best show the diversity of the authors' experiences, their labels were selected as a convenience, not as judgment. The authors were divided into the following groups:
The chart below illustrates experience levels of first authors in cases of publications with multiple authors.
The field of cardiovascular pharmacotherapy holds a promising career landscape for graduate and postgraduate students. If you have discovered an interest in this field through your studies, you may want to further your knowledge or even pursue a career in the cardiovascular health sector. You could explore options such as cardiovascular therapy, internal medicine, cardiology, or Intensive care medicine. For students interested in combining research and medical practice, further study at any of the top-ranking nursing schools in Vermont can open doors to research opportunities, advanced medical practices, and a more profound understanding of the broad topic of cardiovascular health. Grounding your career in research can help expand the existing knowledge and contribute to the progress of cardiovascular pharmacotherapy. It could involve forging a deep understanding of advanced topics such as atrial fibrillation and myocardial infarction. Moreover, equipping oneself with skills to comprehend complex studies like those involving the hazard ratio could also boost career prospects. Work opportunities could range from clinical settings, such as hospitals and private practice, to research institutions. One may also look towards academia, presenting an opportunity to shape the future of cardiovascular pharmacotherapy through education. Career growth in this field is determined by a combination of factors, including academic excellence, research contributions, and hands-on experience.
Vincenzo Castiglione;Martina Chiriacò;Martina Chiriacò;Michele Emdin;Stefano Taddei
(2020)Joshua P Lewis;Joshua D Backman;Jean-Luc Reny;Thomas O Bergmeijer
(2020)Mauro Massussi;Andrea Scotti;Gregory Y H Lip;Riccardo Proietti
(2021)Rinkoo Dalan;Li Wei Ang;Wilnard Y T Tan;Siew-Wai Fong;Siew-Wai Fong
(2021)Claudio Napoli;Giuditta Benincasa;Concetta Schiano;Marco Salvatore
(2020)Angelo Silverio;Marco Di Maio;Costantina Prota;Elena De Angelis
(2021)Luis Ortega-Paz;Mattia Galli;Davide Capodanno;Francesco Franchi
(2021)Antonio Abbate;George F Wohlford;Marco Giuseppe Del Buono;Juan Guido Chiabrando
(2021)Jawad H Butt;Ole De Backer;Jonas B Olesen;Thomas A Gerds;Thomas A Gerds
(2021)Exploring alternative career pathways in healthcare can be a strategic choice for those interested in Medicine in the USA. Many students and professionals seek flexible and cost-effective education options, such as an affordable online MBA healthcare management. This degree offers leadership skills essential for managing health organizations and navigating the evolving medical industry.
For individuals without a nursing background, transitioning directly into nursing roles is possible through programs like the non nursing degree to BSN online. These accelerated programs provide a streamlined pathway to become a registered nurse, meeting the high demand for nursing professionals nationwide.
Specializing further as a nurse practitioner is an appealing option, offering more autonomy and advanced clinical roles. Understanding the pmhnp salary variations by state can help prospective Psychiatric-Mental Health Nurse Practitioners make informed career decisions. Salary prospects vary widely depending on location, experience, and demand.
For those aiming to expedite their nursing careers, knowing how to become a NP in the shortest time is crucial. Accelerated and bridge programs are designed to reduce the timeline without compromising the quality of education.
